Prostate Cancer Reports
54

Volume 5 Number 11
November 2017


Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 11, November



CONTENTS



DIAGNOSIS
FOLLOW-UP, QUALITY OF LIFE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS



Donin NM, Reiter R.
Why targeting PSMA is a game changer in the management of prostate cancer - a Urologist's point of view.
J Nucl Med. 2017 Oct 6. pii: jnumed.117.191874. doi: 10.2967/jnumed.117.191874. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA.
Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.
EJNMMI Res. 2017 Sep 19;7(1):77. doi: 10.1186/s13550-017-0327-7.
Source | Abstract | Full text | Similar articles




Lim Joon D, Lim A, Schneider M, Hiew CY, Lawrentschuk N, Sengupta S, Foroudi F, Jenkins T, Angus D, Wada M, Chao M, Khoo V.
Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation.
Radiother Oncol. 2017 Oct;125(1):113-117. doi: 10.1016/j.radonc.2017.08.031. Epub 2017 Sep 19.
Source | Abstract | Full text | Similar articles




Meyrick DP, Asokendaran M, Skelly LA, Lenzo NP, Henderson A.
The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
Nucl Med Commun. 2017 Nov;38(11):956-963. doi: 10.1097/MNM.0000000000000738.
Source | Abstract | Full text | Similar articles




Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ.
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic MRI.
J Urol. 2017 Sep 12. pii: S0022-5347(17)77497-6. doi: 10.1016/j.juro.2017.09.033. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE



Penson DF.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Oct;198(4):744-745. doi: 10.1016/j.juro.2017.07.033. Epub 2017 Jul 18.
Source | Abstract | Full text | Similar articles




Seftel AD.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Sep;198(3):466-468. doi: 10.1016/j.juro.2017.06.039. Epub 2017 Jun 20.
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Oct;198(4):743-744. doi: 10.1016/j.juro.2017.07.032. Epub 2017 Jul 18.
Source | Abstract | Full text | Similar articles




Waldstein C, Dörr W, Pötter R, Widder J, Goldner G.
Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.
Strahlenther Onkol. 2017 Sep 19. doi: 10.1007/s00066-017-1215-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yafi FA, Sharlip ID, Becher EF.
Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
Sex Med Rev. 2017 Sep 8. pii: S2050-0521(17)30095-1. doi: 10.1016/j.sxmr.2017.08.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT



Sanda MG, Chen RC, Crispino T, Freedland S, Greene K, Klotz LH, Makarov DV, Nelson JB, Reston J, Rodrigues G, Sandler HM, Taplin MH, Cadeddu JA.
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline.
Published 2017. American Urological Association website, accessed 2017 Oct 18.
Source | Abstract | Full text | Similar articles




Sanda MG.
Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Pro.
J Urol. 2017 Sep 22. pii: S0022-5347(17)77389-2. doi: 10.1016/j.juro.2017.08.089. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tosoian JJ, Carter HB.
Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con.
J Urol. 2017 Sep 22. pii: S0022-5347(17)77388-0. doi: 10.1016/j.juro.2017.08.088. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



PROGNOSIS



Al Nemer AM, Elsharkawy T, Elshawarby M, Al-Tamimi D, Kussaibi H, Ahmed A.
The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice.
APMIS. 2017 Sep 15. doi: 10.1111/apm.12741. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Bastian-Jordan M.
Magnetic resonance imaging of the prostate and targeted biopsy, Comparison of PIRADS and Gleason grading.
J Med Imaging Radiat Oncol. 2017 Oct 9. doi: 10.1111/1754-9485.12678. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chalieopanyarwong V, Attawettayanon W, Kanchanawanichkul W, Pripatnanont C.
The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy
Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2555-2559.
Source | Abstract | Full text | Similar articles




Gasser T.
Re: Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-term Oncologic Outcomes in a Shared Equal-access Health System.
Eur Urol. 2017 Sep 20. pii: S0302-2838(17)30727-3. doi: 10.1016/j.eururo.2017.08.034. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hirasawa Y, Ohori M, Sugihara T, Hashimoto T, Satake N, Gondo T, Nakagami Y, Namiki K, Yoshioka K, Nakashima J, Tachibana M, Ohno Y.
No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
Jpn J Clin Oncol. 2017 Sep 8:1-7. doi: 10.1093/jjco/hyx125. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Obata H, Shiota M, Akitake N, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.
Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Anticancer Res. 2017 Oct;37(10):5631-5637.
Source | Abstract | Full text | Similar articles




Reisæter LAR, Fütterer JJ, Losnegård A, Nygård Y, Monssen J, Gravdal K, Halvorsen OJ, Akslen LA, Biermann M, Haukaas S, Rørvik J, Beisland C.
Optimising preoperative risk stratification tools for prostate cancer using mpMRI.
Eur Radiol. 2017 Oct 6. doi: 10.1007/s00330-017-5031-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ruiz-Cerdá JL, Lorenzo Soriano L, Ramos-Soler D, Marzullo-Zucchet L, Loras Monfort A, Boronat Tormo F.
3+4 = 6? Implications of the stratification of localised Gleason 7 prostate cancer by number and percentage of positive biopsy cores in selecting patients for active surveillance.
Actas Urol Esp. 2017 Sep 14. pii: S0210-4806(17)30159-6. doi: 10.1016/j.acuro.2017.07.006. [Epub ahead of print] English, Spanish.
Source | Abstract | Full text | Similar articles




Schulman AA, Howard LE, Tay KJ, Tsivian E, Sze C, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ, Polascik TJ.
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
Cancer. 2017 Jun 29. doi: 10.1002/cncr.30844. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L.
Risk stratification of 'equivocal' PI-RADS lesions in mp-MRI of the prostate.
J Urol. 2017 Sep 20. pii: S0022-5347(17)77559-3. doi: 10.1016/j.juro.2017.09.074. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Winter A, Kneib T, Wasylow C, Reinhardt L, Henke RP, Engels S, Gerullis H, Wawroschek F.
Updated Nomogram Incorporating Percentage of Positive Cores to Predict Probability of Lymph Node Invasion in Prostate Cancer Patients Undergoing Sentinel Lymph Node Dissection.
J Cancer. 2017 Aug 22;8(14):2692-2698. doi: 10.7150/jca.20409. eCollection 2017.
Source | Abstract | Full text | Similar articles



TREATMENT



Borghetti P, Spiazzi L, Cozzaglio C, Pedretti S, Caraffini B, Triggiani L, Greco D, Bardoscia L, Barbera F, Buglione M, Magrini SM.
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further.
Radiol Med. 2017 Sep 18. doi: 10.1007/s11547-017-0807-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Chandrasekar T, Goldberg H, Klaassen Z, Sayyid RK, Hamilton RJ, Fleshner NE, Kulkarni GS.
Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes.
Urol Oncol. 2017 Sep 14. pii: S1078-1439(17)30454-4. doi: 10.1016/j.urolonc.2017.08.023. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Fucikova J, Podrazil M, Jarolim L, Bilkova P, Hensler M, Becht E, Gasova Z, Klouckova J, Kayserova J, Horvath R, Fialova A, Vavrova K, Sochorova K, Rozkova D, Spisek R, Bartunkova J.
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.
Cancer Immunol Immunother. 2017 Sep 25. doi: 10.1007/s00262-017-2068-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Isharwal S, Stephenson AJ.
Post-prostatectomy radiation therapy for locally recurrent prostate cancer.
Expert Rev Anticancer Ther. 2017 Nov;17(11):1003-1012. doi: 10.1080/14737140.2017.1378575. Epub 2017 Sep 18.
Source | Abstract | Full text | Similar articles




Montorsi F, Gandaglia G, Fossati N, Suardi N, Pultrone C, De Groote R, Dovey Z, Umari P, Gallina A, Briganti A, Mottrie A.
Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
Eur Urol. 2017 Sep;72(3):432-438. doi: 10.1016/j.eururo.2016.08.051. Epub 2016 Sep 3.
Source | Abstract | Full text | Similar articles




Pansadoro V, Brassetti A.
Re: Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
Eur Urol. 2017 Sep 25. pii: S0302-2838(17)30782-0. doi: 10.1016/j.eururo.2017.09.018. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yoo S, You D, Kim YS, Hong JH, Ahn H, Kim CS.
Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
Urol Int. 2017 Oct 12. doi: 10.1159/000481265. [Epub ahead of print]
Source | Abstract | Full text | Similar articles